We are live on ! Find out more
CYCN icon

Cyclerion Therapeutics
CYCN

80 hedge funds and large institutions have $49.1M invested in Cyclerion Therapeutics in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 16

17% more capital invested

Capital invested by funds: $41.8M → $49.1M (+$7.29M)

4% more funds holding

Funds holding: 77 → 80 (+3)

0.54% more ownership

Funds ownership: 2.8% → 3.34% (+0.54%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 22

Holders
80
Holders Change
+3
Holders Change %
+3.9%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
19
Reduced
22
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SPC
Slate Path Capital
New York
+$4.27M
2
MP
MFN Partners
Massachusetts
+$3.35M
3
EC
EcoR1 Capital
California
+$3.32M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$2.42M
5
AG
Artal Group
Luxembourg
+$1.78M

Top Sellers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
-$952K
2
AC
AWH Capital
Texas
-$945K
3
PAM
Panagora Asset Management
Massachusetts
-$832K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$662K
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$471K
Name Holding Trade Value Shares
Change 		Change in
Stake
Squarepoint
76
Squarepoint
New York
– -$372K -6,846 Closed
MAP
77
Madison Avenue Partners
New York
– -$361K -6,628 Closed
Two Sigma Investments
78
Two Sigma Investments
New York
– -$267K -4,906 Closed
State of Wisconsin Investment Board
79
State of Wisconsin Investment Board
Wisconsin
– -$96K -1,774 Closed
ARTA
80
A.R.T. Advisors
New York
– -$66K -1,210 Closed
Susquehanna International Group
81
Susquehanna International Group
Pennsylvania
– -$50K -912 Closed
Tudor Investment Corp
82
Tudor Investment Corp
Connecticut
– -$49K -903 Closed
AA
83
AQR Arbitrage
Connecticut
– -$40K -742 Closed
Norges Bank
84
Norges Bank
Norway
– -$34K -623 Closed
OAM
85
Oxford Asset Management
United Kingdom
– -$32K -589 Closed
Ohio Public Employees Retirement System (OPERS)
86
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$12K -229 Closed
Bank of Montreal
87
Bank of Montreal
Ontario, Canada
– -$8K -153 Closed
CSS
88
Cubist Systematic Strategies
Connecticut
– -$2K -31 Closed
ASN
89
Advisory Services Network
Georgia
– +$71 +1 New
EI
90
Ellevest Inc
New York
– +$71 +1 New
Simplex Trading
91
Simplex Trading
Illinois
– +$571 +8 New
1 2 3
4

CYCN Hedge Fund Activity: Q1 2020 in Review

80 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Cyclerion Therapeutics (CYCN) for Q1 2020, worth a combined $49.1M — up 17% from $41.8M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CYCN positions and 16 closed out — a net gain of 3 holders — while 19 added to existing stakes and 22 trimmed.

The largest buyer was Slate Path Capital, opening a new position worth an estimated $4.27M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $952K sold.

  • 80 institutional investors held Cyclerion Therapeutics (CYCN) as of Q1 2020, up from 77 in Q4 2019.
  • Funds reported $49.1M of Cyclerion Therapeutics stock for Q1 2020, up 17% quarter-over-quarter.
  • 19 funds opened new Cyclerion Therapeutics positions in Q1 2020 and 16 closed out, a net change of +3 holders.
  • The largest Cyclerion Therapeutics buyer in Q1 2020 was Slate Path Capital, an estimated $4.27M added.
  • The largest Cyclerion Therapeutics seller in Q1 2020 was Farallon Capital Management, an estimated $952K sold.

Based on aggregated 13F filings for Q1 2020.